Real-world healthcare utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir® HFA) with and without integrated dose counters

Real-world healthcare utilization in asthma patients using albuterol sulfate inhalation aerosol (ProAir® HFA) with and without integrated dose counters

Edward M Kerwin,1 Thomas J Ferro,2 Rinat Ariely,3 Debra E Irwin,4 Ruchir Parikh3 1Clinical Trials Division, Clinical Research Institute of Southern Oregon, PC, Medford, OR, 2Global Medical Affairs, 3Global Health Economics and Outcome Research, Teva Pharmaceuticals, Frazer, PA, 4Outcomes Research, T...

Full description

Bibliographic Details
Main Authors: Kerwin EM, Ferro TJ, Ariely R, Irwin DE, Parikh R
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:Journal of Asthma and Allergy
Subjects:
Asthma
ProAir
Integrated dose counters
Respiratory-related hospitalizations
Emergency department visits
Lower respiratory tract infections-related outpatient visits
Online Access:https://www.dovepress.com/real-world-healthcare-utilization-in-asthma-patients-using-albuterol-s-peer-reviewed-article-JAA

Internet

https://www.dovepress.com/real-world-healthcare-utilization-in-asthma-patients-using-albuterol-s-peer-reviewed-article-JAA

Similar Items